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ABSTRACT
The American Society of Human Genetics (ASHG) recommends that testing for
adult onset conditions be deferred until adulthood because of the potential for psychological
harm combined with lack of medical utility. ASHG’s 2016 DNA Day Essay Contest asked 912th graders to defend or refute this position. 1241 essays were submitted. 572 students
defended ASHG’s position statement, while 554 argued against. Essays that addressed
Alzheimer’s disease (AD) and BRCA-related Hereditary Breast and Ovarian Cancer
syndrome were qualitatively analyzed for themes related to the argued position. 64.4% of
students argued for deferred testing of AD, and 46.1% of students argued for deferred testing
of BRCA. Relevant themes include the availability or lack of medical intervention, potential
psychological benefit or consequence, and genetic testing variability and uncertain
predictability. This data suggests that minors have thoughtful and insightful opinions that
should be taken into consideration when considering predictive genetic testing.
KEYWORDS: Predictive testing, presymptomatic testing, minors, adolescents, adult onset, ASHG,
ethics, perspectives, attitudes, genetic testing

INTRODUCTION
The introduction of genetic testing into clinical care has brought with it many obvious
benefits, but also a great deal of uncertainty. In particular, it has raised ethical concerns about
the potential downsides of predictive information. Predictive testing, done in the absence of
any sign or symptom of disease, requires considerable forethought. While testing for adult
onset disorders is accepted as a reasonable option for adults who wish to know their risk for
late-onset conditions, a cautious approach is taken when considering predictive testing for
children and adolescents. Disputes arise when clinicians, families, or minors themselves

consider testing for adult onset conditions before symptoms present and when there is no
impact on medical care before adulthood.
Scientists are increasingly identifying genes and other biological markers that can
provide presymptomatic and predictive risk estimates for developing an adult onset disorder
(Roberts, Cupples, Relkin, Whitehouse, & Green, 2005). Two common examples of adult
onset disorders are Alzheimer’s disease (AD) and Hereditary Breast and Ovarian Cancer
Syndrome (HBOC). AD is a degenerative brain disorder that causes behavioral problems and
gradual loss of memory. The common form of this disease usually presents in people over
65; however, there is a genetic variant that causes the onset of disease earlier in adulthood.
Finding that one carried this variant would indicate a predisposition to potentially developing
symptoms much earlier in life. HBOC is a syndrome most commonly caused by a mutation
in the BRCA1 gene or BRCA2 gene that results in a dramatically increased lifetime risk of
developing breast and/or ovarian cancer.
The debate surrounding presymptomatic testing in minors is complex. The most
widely accepted ethical justification for genetic testing of minors is the direct benefit of
medical intervention or preventative measures (Borry, Stultiens, Nys, Cassiman, & Dierickx,
2006). In addition, minors and their families may choose to be tested to alleviate uncertainty
or to develop a long-term plan for the future. Commonly cited reasons to avoid testing are
fear that this information could create social, emotional, psychological, and educational
consequences for minors (Borry, et. al., 2006). Because of these and additional concerns,
clinical guidelines and position papers often discourage presymptomatic and predictive
testing in minors, including guidelines from the American Society of Human Genetics
(ASHG), the National Society of Genetic Counselors (NSGC), and the American Academy

of Pediatric (AAP). Guidelines typically emphasize that the age of testing should be flexible,
but that genetic testing should be deferred to ensure that adolescents are competent enough to
make an informed decision (Borry, et. al., 2006).
For clarity, this paper uses the words “adolescent,” “minor,” “student,” and “young
person” interchangeably as all-encompassing terms for a high school-aged person, ages 1418.

Arguments Against Predictive Testing of Minors
Reasons to support the deferral of genetic testing until the age of 18 are considered
extensively throughout the literature. Several studies that have looked at the consequences of
predictive testing in adolescents assert that the disadvantages are mainly psychological in
nature (Bradbury, Patrick-Miller, Ibe, Cummings, Olopade, & Daugherty, 2008). Potential
psychological consequences that individuals have experienced with early testing are cited
across studies, including increased disease-related stress and anxiety, distortion of family
relationships, interference with normal development of self-concept, and feelings of
unworthiness (Bradbury, et. al., 2008). Additionally, a positive test result has been reported
to cause a loss of self-esteem, stigmatization, and lowered expectations within the family if
parents limit horizons for gene-positive minors, resulting in adolescent loss of self-worth
(Wertz, Fanos, & Reily, 1994).
Another argument against the genetic testing of minors is that it compromises what is
often referred to as an “open future.” The right to an open future is an argument based on
autonomy, and suggests that the minor’s right to make decisions for him or herself as an
adult should be preserved to the greatest extent possible (Bredenoord, de Vries, & van
Delden, 2014). This “open future” argument asserts that people have different concepts of

what a “good life” entails and have differing opinions about the pros and cons of genetic
testing—therefore, individuals should be able to make their own choices according to their
own values, and not have those decisions curtailed by parental or other forms of surrogate
decision making (Bredenoord, et. al., 2014).

Arguments in Favor of Predictive Testing of Minors
There is a growing need to understand the psychological consequences of predictive
testing (Michie, Bobrow, & Marteau, 2001). The main argument in support of testing
adolescents for adult onset disorders is that testing has the potential to impact behaviors that
will affect their future health (Bradbury, et. al., 2008). Many practitioners believe that some
adolescents are not only equipped to handle the information, but are also able to take the
information and act upon it. By engaging in healthy behaviors or starting early surveillance
and management, studies suggest that they may be able to decrease or postpone their risk of
developing symptoms of the disease (Aatre & Day, 2011). Some medical professionals
believe that in certain instances, minors will indeed benefit psychologically from the
information, giving them both relief of having identified their condition early and a feeling of
control (Aatre & Day, 2011). Although there is a concern that predictive testing in unaffected
minors could induce unnecessary anxiety and distress, some data actually suggests the
opposite, revealing that testing can provide reassurance, lessen uncertainty, and promote a
healthy sense of control (Aarte & Day, 2011).
Further, some experts have proposed that genetic testing can have a positive effect on
relationships, decrease anxiety and depression, and encourage open communication. Through
such communication, gene-positive minors have the ability to become active participants in
their health. This may help to reduce stigmatization and ease requests for help if needed in

the future (Duncan & Delatycki, 2006; Mand, Gillam, Delatycki, & Duncan, 2012).
Withholding genetic information may squander the opportunity for a young person to take
ownership of their genetic status and incorporate it as part of their identity (Anderson,
Hayeems, Shuman, Szego, Monfared, Bowdin, & Meyn, 2015).
Another proposed reason to allow predictive genetic testing at a younger age is for
planning purposes. Early testing allows for parents to properly prepare for their child’s
future, and allows children time to adjust while still having the oversight and support of their
parents (Rhodes, 2006). A review of studies described that both healthcare professionals and
young adults recognized that family and reproductive planning is quickly approaching at the
time of testing. In order to proactively prepare for one’s future, young adults consider it
beneficial and necessary to go through the process of predictive genetic testing (Mand, et. al.,
2012).

Current Research on Predictive Testing in Adults and Adolescents
While there have been many studies on the emotional impact of genetic testing on
adults, much less is known about the impact on children and adolescents, who are often
deemed more “vulnerable to emotional distress” than adults (Michie, et. al., 2001).
In one influential study called the REVEAL (Risk Evaluation and Education for
Alzheimer’s Disease) study performed by Roberts, Cupples, Relkin, Whitehouse, and Green
(2005), 162 adults with a family history of AD were randomly assigned to the disclosure of
results group or the nondisclosure of results group. The final analysis suggested that risk
assessment and genotype disclosure did not adversely affect the psychological wellbeing of
the adults in the study. In fact, following risk disclosure, 90% of all participants reported the
same or lower anxiety regarding their risk of developing AD compared with baseline levels.

However, the participants with negative results were more likely to report lower levels of
anxiety. In addition, there was an increase in preventative lifestyle changes in the group that
tested positive for the high risk allele, APOE4. This study suggests that psychological
outcomes can be neutral in regard to pre-symptomatic testing, and that some patients will
actually take the preventative measures despite the overwhelming information.
In one of the few studies that examined the emotional impact of predictive genetic
testing on minors, Michie, Bobrow, and Marteau (2001) focused on individuals tested for
familial adenomatous polyposis (FAP). The study’s main objective was to determine if
minors aged 10-16 or adults who received positive results following predictive testing for
FAP experienced significant levels of anxiety or depression. The 10-16 year-olds who
received positive results were slightly more anxious and depressed than those who received
negative results. However, the minors receiving positive or negative results did not show
higher levels of anxiety or depression than adults in comparable circumstances.

Testing Recommendations in the United States
The development of technologies that can test asymptomatic minors for adult onset
diseases creates a number of ethical and legal issues (American Society of Human Genetics
& American College of Medical Genetics, 1995). To facilitate agreement on the points of
contention surrounding these issues, ASHG and the American College of Medical Genetics
and Genomics (ACMG) jointly released a statement regarding the testing of minors in 1995
(ASHG & ACMG, 1995). This publication was influential in guiding clinicians and families
during a time in which numerous genetic tests were introduced, particularly presymptomatic
and predictive tests (Botkin, Belmont, Berg, Berkman, Bombard, Holm, Levy, Ormond, Saal,
Spinner, Wilfond, & McInerney, 2015).

As knowledge of genetics and genomics continued to grow, so did the public interest
in issues related to genetic testing and the expanded use of this type of testing (Friedman
Ross, Saal, David, & Anderson, 2013). As a result, the topic of testing minors was revisited
in 2015, when ASHG released an independent position statement. A new statement was
deemed appropriate, given the evolution of testing combined with the mounting questions
and concerns raised in regards to testing minors (Botkin, et. al., 2015).
The 2015 ASHG statement recommends that unless there is an available and
appropriate clinical intervention during childhood, predictive or presymptomatic testing for
adult onset conditions should be deferred at minimum until the minor is a consenting adult
who can participate in medical decision making (Botkin, et. al., 2015). However, ASHG
recommends that providers acknowledge that in some cases, testing might be reasonable after
thorough consideration and clinical evaluation. In some circumstances, facilitating predictive
testing for a minor may be justified. For example, if it can alleviate significant psychosocial
stress within a family or ease life-planning decisions, then testing may be justifiable. Botkin,
et. al. (2015) noted that empirical research on the psychosocial impact of predictive and
presymptomatic testing is limited and suggested that more research is necessary for future
policy recommendations.
In February of 2017, the National Society of Genetic Counselors (NSGC) updated its
position statement regarding the genetic testing of minors for adult onset conditions. NSGC
briefly states that the deferral of predictive testing of minors is preferable, and optimally
should be deferred when the results will not impact childhood medical decisions or
management. They also encourage deferring this type of testing until the minor has the
“capacity” to consider the risks, benefits, and limitations of such testing. NSGC states,

“his/her circumstances, preferences, and beliefs [should be taken] into account to preserve
his/her autonomy and right to an open future” (NSGC, 2017).
The American Academy of Pediatrics (AAP) also recommends deferring predictive
testing until adulthood “unless an intervention initiated in childhood may reduce morbidity or
mortality.” They also add as an exception to this recommendation that testing may be
deemed appropriate for a family experiencing “significant psychosocial burden” (AAP Policy
Statement, 2013).

Testing Recommendations in Foreign Countries
In general, similar points have been made by genetic societies worldwide that have
taken a stance on the predictive testing of minors. In Canada, the Canadian Paediatric Society
(CPS) states that, ideally, the decision to test should be made with the minor, when he/she is
competent enough to make the decision (CPS, 2003). Though CPS believes that adolescents
are not able to be completely autonomous in these situations, they recognize that, “it does not
seem justified…to refuse testing to a fully informed, competent adolescent who is requesting
[genetic testing]” (CPS, 2003).
The European Society of Human Genetics (ESHG) and the Human Genetic Society of
Australasia (HGSA) have made recommendations that “the best interests of the young person
must prevail” (HGSA, 2014) and the opinion of the minor should be taken into consideration
“as an increasingly determining factor in proportion to his or her age or degree of maturity”
(ESHG, 2009). ESHG stresses that well-informed minors with an adequate understanding of
the test and its potential implications should be considered competent to make the decision
for his or herself (ESHG, 2009). ESHG and HGSA suggest that predictive testing for an adult
onset condition is acceptable only if there are available preventative measures that can be

taken (ESHG, 2009, HGSA, 2014).
Compared to the United States, Europe, and Canada, the age at which minors are
considered autonomous is much younger in Australia. In fact, the HGSA does not
recommend a specific age to differentiate between who can make an informed decision and
who cannot—each request for testing requires “individual assessment” (HGSA, 2014). In
Australia, adolescents are divided into immature and mature youths based on their cognitive
capacity and psychosocial maturity, and are then deemed able to make fully formed decisions
after a full psychosocial assessment (HGSA, 2014).

The Need for Adolescent Opinions
With the limited research focused on the predictive testing of minors, existing
guidelines are based on suggestions and speculation by clinicians and bioethicists. Notably,
there is a voice lacking in this discussion: the adolescents themselves. The voices of young
adults continue to be scarce despite the important role their opinions play in shaping existing
guidelines and practices (Duncan, Gillam, Savulescu, Williamson, Rogers, & Delatycki,
2008). Thus, the focus of our project is to unveil adolescent perspectives regarding genetic
testing for adult onset conditions. More specifically, we seek to uncover how their opinions,
as reflected in essays written by minors for ASHG’s annual DNA Day Essay Contest, align
with ASHG’s position statement on genetic testing of minors.

MATERIALS & METHODS
Study Design
Essays were submitted by 9th-12th grade students (roughly ages 14-18) to ASHG’s
annual 2016 international DNA Day Essay Contest. Essays were thematically analyzed using

a mixed-methods approach. This analysis was used to investigate reasons why minors would
defer or not defer genetic testing for adult onset disease. Demographic information including
gender, grade, and submission location were also analyzed. All essays were uploaded into the
qualitative analysis program Atlas. Qualitative analyses were conducted using a grounded
theory approach to assess minors’ views and arguments for and against testing for adult onset
conditions.

Participants & Essay Question
ASHG’s 2016 DNA Day essay contest question was as follows:
Choose a genetic test that is currently available for a condition or disease that does not cause
symptoms until adulthood (i.e., an adult-onset condition such as hereditary breast cancer).
Describe how the test works and how certain the test results are. Then, either defend or refute
the recommendation below from ASHG’s recent position statement on pediatric genetic
testing.
“Adolescents should be encouraged to defer predictive or pre-dispositional
testing for adult-onset conditions until adulthood because of the complexity
of the potential impact of the information at formative life stages.”

Teachers entered essays on behalf of their students, and a total of 1241 essays were
submitted. Teachers could submit essays from up to six students per class for up to three
classes. Participants were informed that essays might be used for research purposes. This
study received an exemption from the Sarah Lawrence College Institutional Review Board
(IRB) in April 2016 along with an approval from the Geisinger Health System IRB in March
2016.

Initial Evaluation of Data
All essays were categorized by grade, sex, chosen disease, and whether or not the
student chose to defer testing until adulthood. Essays that did not focus on a single disease

were titled ‘None’ in the disease category, and the essays that did not pick defer or not defer
were labeled ‘Other.’ To ensure accuracy, 150 essays were randomly selected to cross-check
labeling.
Once the essays were labeled and cross-checked, they were grouped into categories
based on their content. The essays that were marked ‘Other’ or ‘None’ were reviewed to
determine if the information could be used to identify a position regarding the testing of
minors. A total of 77 essays that did not contribute valid information were discarded.
Reasons for discarding None/Other essays included:
·

Essay did not address essay prompt or focused on a different topic

·

Essay was illegible or unintelligible

·

Essay did not state an opinion

·

Essay misinterpreted question/ASHG policy

Reasons for keeping None/Other essays included:
·

Essay indicated personal/family/individual choice

·

Essay showed an understanding of the question and represented both sides of the

argument without choosing a single side
Decisions were made by consensus among all coders. Essays that were kept were uploaded to
Atlas and remained in a separate category named ‘None/Other.’

Developing Codebook and Analysis Framework
To create the codebook, the three most common disorders were identified (HD, AD,
& BRCA), and all essays referencing those disorders were assigned two readers. Themes and
categories based on the essays’ content were identified and served as the basis for an

inductive data analysis. Lists of topics were assembled by each coder and then combined to
build a holistic picture of the essays’ content. Coders continued reading until a saturation
point was reached when no new themes emerged. Subsequently, coders combined their
findings and then integrated all themes into categories. An initial codebook was established
by consensus and reviewed by an external supervisor.
The clarity of the codes was checked through an iterative process to ensure the codes
were applied appropriately and consistently. To start, all investigators were given five
randomly selected sentences to apply the relevant codes. The process was repeated until
reviewer agreement indicated that the codes were unanimously defined. Next, once the
codebook was agreed upon, five essays were assessed by each coder separately, and then
compared. This process was repeated until all readers were consistently applying the same
codes to the same themes found in the essays. Once inter-rater reliability (IRR) was reached,
essays were divided among 4 coders to code independently. The IRR was 0.95 alpha (≥0.75
IRR), allowing the data to be analyzed in Atlas.

Codebook
The final codebook contained 25 codes (Table I.). Twenty four of the codes have a
counterpart; for example, Code 1: Psychological benefit to minor is paired with Code 2:
Psychological risk to minor. Each code consisted of a general category, an explanation of the
themes/topics that related to that category, and example statements for when to apply the
code to avoid code drift.

Code Number and Code

1.

Psychological
benefits to minor

13.

Disrupts formative years

2.

Psychological risks
to minor

14.

Social risks

3.

Genetic testing
variability and
uncertain
predictability

15.

Social benefits

4.

Genetic testing
accuracy and
predictability

16.

Mature and incapable

5.

Factual
genetic/disorder
information

17.

Immature and capable

6.

Incorrect facts

18.

Potential discrimination

7.

Risks to family

19.

Necessary to
plan/prepare

8.

Benefits to family

20.

Unnecessary to
plan/prepare

9.

Personal experience
with the condition

21.

Advancements in science

10.

Personal experience
with testing

22.

Case-by-case

11.

Medical benefit or
prevention

23.

Loss of autonomy

12.

No medical benefit
or prevention

24.

Individual’s choice

25.

Family/Parent’s choice

Table I. The complete list of 25 codes.

Thematic Analysis (ATLAS.ti)
Of the 1241 essays submitted, 313 essays that discussed BRCA, Lynch, and
Alzheimer’s disease (189, 13, and 111, respectively) were thematically coded. For the

purposes of this analysis, only the essays that discussed BRCA and AD were analyzed for
thematic content relating to the reasons to defer or not defer genetic testing for adult onset
conditions.

RESULTS
There were 1241 student essays submitted to the ASHG DNA Day Essay Contest.
The majority of submissions (87%) were from the United States while a smaller number of
essays (13%) were submitted by international students. Figure 1. depicts the number of
essays submitted from each US state. Six states submitted no essays. The maximum number
of essays submitted was 186 (New York). Of the 44 states that participated, the average
number of essay submissions was 28.

Figure 1. Map of the United States depicting the number of essay submissions. A darker color correlates
with a higher number of essay submissions. White indicates no essays were submitted.

Females submitted 67% of the essays and males submitted 37%. The majority of
essays (88%) were evenly distributed between grades 10-12, and 9th graders represented the
remaining 12%. Over 100 conditions were discussed by the students, but 60 of them were

mentioned by only one student. The five most commonly discussed conditions are listed in
Table II.

Table II. Five most common adult onset conditions chosen, including discarded essays.

Across all essays, students were almost evenly split on whether they agreed or
disagreed with the ASHG recommendation to defer testing until adulthood, as depicted in
Table III.

Table III. Testing decision breakdown across all essays.

A statistically significant association was seen between which condition the student
chose to discuss and whether or not the student supported deferring genetic testing (p<.01).
While 64.4% of the students who submitted AD essays were in favor of deferring testing,
only 46.1% of the students who submitted BRCA essays were in favor of deferring testing.
Similarly, more BRCA essays supported not deferring testing (53.9%) than AD essays
(35.6%) (Table IV). No association was found between sex or grade and the decision to defer
or not defer in the comparison of BRCA and AD essays (Appendix A).

Defer vs. Not Defer for Alzheimer's and BRCA

Defer

Count
%

Alzheimer’s
67
64.4%

Not
Defer

Count

37

97

134

%

35.6%

53.9%

47.2%

Count
%

104
100.0%

180
100.0
%

284
100.0%

Total

BRCA
83
46.1%

Total
150
52.8%

Chi-square (1) = 8.87, p<.01

Table IV. Chi square table showing percentage breakdown between defer and not defer in Alzheimer’s
and BRCA essays. Chi-square (1) value was found to be 8.87 with a p value of <.01, making the difference
between the condition chosen and whether or not to defer significant.

Figure 2. Bar graph depicting the number of defers and not defers in Alzheimer’s and BRCA essays.
Green bars represent BRCA essay choices while blue bars represent Alzheimer’s essay choices.

AD and BRCA essays were examined for correlations between students’ choices to
defer or not defer. Table V and VI include the five most commonly used codes and their
counter code. The top three most commonly used codes were examined for the purpose of
extracting thematic quotes.

BRCA Thematic Categories

All

Defer

Not Defer

Psychological benefits to minor

78

8

67

Psychological risks to minor

248

179

53

Genetic testing variability and uncertain predictability

202

144

53

Genetic testing accuracy and predictability

19

9

10

Medical benefit/prevention

239

41

185

No medical benefit/not preventable

78

65

5

Mature and capable

24

1

23

Immature and incapable

73

63

7

Necessary to plan/prepare

100

10

86

Unnecessary to plan/prepare

13

12

1

Table V. Top five commonly used codes and their counter code within BRCA essays. Note: the defer and
not defer columns do not add up to the total because there were None/Other essays included in the “all”
column.

Alzheimer's Thematic Categories

All

Defer

Not Defer

Psychological benefits to minor

31

6

21

Psychological risks to minor

133

107

16

Genetic testing variability and uncertain predictability

162

125

26

Genetic testing accuracy and predictability

3

3

0

Medical benefit/prevention

66

15

47

No medical benefit/not preventable

68

59

6

Mature and capable

12

0

10

Immature and incapable

26

25

0

Necessary to plan/prepare

56

9

44

Unnecessary to plan/prepare

7

7

0

Table VI. Top five commonly used codes and their counter code within AD essays. Note: the defer and
not defer columns do not add up to the total because there were None/Other essays included in the all
column.

For the BRCA essay submissions that chose to defer, statements under the codes
‘psychological risks,’ ‘genetic testing variability and uncertain predictability,’ and ‘no
medical benefit or prevention’ were mentioned the most. Those who chose to not defer
discussed ‘medical benefit and prevention,’ ‘necessary to plan or prepare,’ and
‘psychological benefits’ the most. In two of the six most common codes applied to the defer
and not defer essays there was a direct contrast: while the defer essays discussed
‘psychological risks’ and ‘no medical benefit or prevention,’ the not defer essays discussed
‘psychological benefits’ and ‘medical benefit or prevention’ (Table VII.).

Essay Totals (189)

Defer (83)

Not Defer (97)

BRCA’s Top Codes
(Number of times code was found within the essays)

Psychological Risks
(179)

Genetic Testing Variability
and Uncertain Predictability
(144)

No Medical Benefit or
Prevention (65)

Medical Benefit and
Prevention (185)

Necessary to Plan or
Prepare (86)

Psychological Benefits
(67)

Table VII. Top three codes represented in BRCA essays in the decision to defer or not defer.

In the AD student essays that chose to defer, the most commonly discussed reasons
were ‘genetic testing variability and uncertain predictability,’ ‘psychological risk,’ and ‘no
medical benefit or prevention.’ Those who chose to not defer most frequently discussed
‘medical benefit and prevention,’ ‘necessary to plan or prepare,’ and ‘genetic testing
variability and uncertain predictability.’ Two of the codes applied to the defer and not defer
essays directly contrasted with one another: ‘no medical benefit or prevention’ with defer and
‘medical benefit and prevention’ with not defer, while the code ‘genetic testing variability
and uncertain predictability’ was used for both (Table VIII.).

Essay Totals (111)

Alzheimer’s Top Codes
(Number of times code was found within the essays)

Defer (67)

Genetic Testing Variability
and Uncertain Predictability
(125)

Psychological Risks
(107)

No Medical Benefit or
Prevention (59)

Not Defer (37)

Medical Benefit and
Prevention (47)

Necessary to Plan or
Prepare (44)

Genetic Testing Variability
and Uncertain
Predictability (26)

Table VIII. Top three codes represented in AD essays in the decision to defer or not defer.

In both BRCA and AD essays the decision to defer was most commonly associated
with the same three codes, although the order of the most common and second most common
codes was reversed. The decision to not defer had the same top two codes in the same order
(‘medical benefit and prevention’ and ‘necessary to plan or prepare’); however, the third
most used code for the decision to not defer was not shared between the two conditions
(‘psychological benefit’ versus ‘genetic testing variability and uncertain predictability’). Of
note, because there were fewer essays discussing AD than BRCA, the codes were applied
fewer times overall.
There was no association found between the number of times a code was applied and
a student’s sex or grade. All of the essays contained the code ‘factual genetic/disorder
information.’ A complete list of correlations can be found in Appendix A.

DISCUSSION
There were several limitations of this study. Notably, this is not a representative
sample of adolescents: only 1241 essays were submitted, six states did not submit any essays,
67% of the essays were submitted by females, and the majority of essays analyzed were from

the United States (87%). It is unclear whether the essay prompt was assigned to the entire
class or if only the students who had the motivation to write an essay for the contest entered
their submissions. In addition, teachers may have hand selected what they believed were the
best essays to submit. Moreover, only two conditions were analyzed thematically, and these
two conditions combined only make up half of the essays submitted. It is possible that upon
further analysis of all essays, different codes could be emphasized.
The data gathered from these essays suggests that minors are insightful about
predictive testing for adult onset conditions when given an outlet to express their opinions.
Upon initial analysis, it seemed that the choice to defer or not defer was almost evenly split.
However, when examined more thoroughly, their views on deferral were more complex and
appeared to depend on the condition they chose. It is possible that upon learning about the
ASHG position statement, students were inclined to inherently agree with a medical
recommendation, regardless of the disease they chose. Another possibility is that a student’s
initial opinion concerning genetic testing of minors influenced the condition chosen.
Additional qualitative analysis helped to identify possible reasons why these disease-specific
themes emerged.

Defer Essay Themes
Students who chose to defer testing often cited the same reasons discussed in the
clinical guidelines. One such theme that presents in both the BRCA and AD essays is
‘psychological risks.’ One student discussing the psychological risks of deferring BRCA
testing stated, “Overall, adolescents should not be tested for genetic diseases because of the
emotional trauma that it can inflict on the person” (Essay 1128, BRCA, Defer).

It is apparent that when weighing whether or not to defer testing, minors consider the
emotional and psychological implications of genetic testing. This was noted in an AD essay
in which a student states, “Because there is no cure and limited treatment for Alzheimer’s
disease, oftentimes predictive genetic testing leads to depression and psychological
problems” (Essay 1105, AD, Defer). The potential adverse psychological outcomes that
coincide with a positive genetic test result are clearly recognized by students and used to
defend their stance on deferring testing.
Even for conditions that have medical management options, ‘no medical benefit or
prevention’ was chosen as a top code to defer because the disease does not occur until
adulthood. “In the case of breast and ovarian cancers caused by BRCA mutations, there are
preventative measures…However, since cancer does not appear until adulthood- the average
age of diagnosis is 42 for breast and 52 for ovarian cancers (Brose et al, 2002)- this does not
apply to adolescents,” as one student wrote (Essay 141, BRCA, Defer). This expresses the
idea that minors may defer testing based on the absence of immediate medical benefit, a
notion also included in the ASHG guidelines.
The final most commonly used reason for deferring testing was the variable and
unpredictable nature of genetic testing. An AD student’s essay states, “It is important to note
that having the APOE e4 allele does not cause the disease; the presence of the e4 allele is
only one of the many factors that increase risk of development. Currently, no definitive test
exists for the discovery of Alzheimer’s disease in a living individual; the only conclusive test
is an autopsy” (Essay 5, AD, defer). Similarly, a student who chose BRCA argued, “A
positive test result does not mean that a person will definitely develop the cancers, it only
indicates that the person has an increased risk” (Essay 934, BRCA, Defer). Because there is

no straightforward genetic testing result for AD and BRCA, many students suggested that it
would not be beneficial to get genetic testing as a minor. This argument is not mentioned in
ASHG’s position statement, but it seems to be important to minors.
BRCA and AD defer essays had the same three most common codes. Despite
evidence that the reasons behind their decision to defer were similar, there were significantly
more students who chose to defer testing for AD than BRCA. A possible reason for this
finding may be due to the lack of medical surveillance and management options for
Alzheimer’s disease. By comparison, if someone is found to carry a BRCA mutation, there is
medical management available; individuals could increase their cancer screening and
consider prophylactic options. For AD, there are only clinical trials in place as a possible way
to slow progression of the disease.

Not Defer Essay Themes
The top two codes used in support of not deferring testing were ‘medical benefit’ and
‘genetic testing variability and uncertain predictability.’ These codes were the same in both
BRCA and AD essays. An example of the most common argument states that, “adolescents
should be encouraged to receive genetic testing if there is a chance they may have the
BRCA1 or BRCA2 mutations to give them a chance to receive medical care to help prevent
the development of breast or ovarian cancer in the future” (Essay 1101, BRCA, Not Defer).
When considering AD, one student wrote, “I believe genetic testing is a positive way to find
new things out about a certain disorder or mutation in DNA. You should take the opportunity
of having a test done to prepare yourself for the future to live out a healthier and more
preventative lifestyle” (Essay 868, AD, Not Defer), demonstrating that there are perceived

medical benefits to early testing.
The third most common code noted in association with the decision to not defer
testing in AD essays was particularly interesting and unexpected. Students mentioned
‘genetic testing variability and uncertain predictability’ third most despite deciding to not
defer testing. This may indicate that even though students opted to proceed with testing, they
found the genetic testing to be uncertain. Possible reasons they decided to not defer despite
uncertainty in genetic testing were because they found the reasons to have genetic testing
stronger than the unpredictability of the test. One student relates a version of this idea by
saying, “It should be encouraged for adolescents to take predictive or pre-dispositional
testing...They need to be prepared for the reality that they indeed have the mutant gene
however that does not mean that they are certainly going to get the illness” (Essay 216, AD,
Not Defer). Another student’s argument supports this idea by saying, “Researchers believe
genetic testing will never be able to predict the disease with 100 percent accuracy due to
environmental factors (The Genetics of Disease). Many people find this new technique to
ease their anticipation that results from the unknown possibility of developing a fatal
disease” (Essay 499, AD, Not Defer).
Another reason that ‘genetic testing variability and uncertain predictability’ was used
repeatedly may be due to the essay prompt itself. The prompt explicitly instructs students to
“describe how the test works and how certain the test results are.” While researching a
condition, information on genetic testing uncertainty is readily available. It is likely that
students included the uncertainty and variable predictability of genetic testing because it was
required to discuss this aspect of their chosen genetic condition.

Conclusions
To help evaluate predictive testing on an individual level, genetic counselors should
play an integral role in explaining the testing options, granting autonomy to the person
pursuing testing. The theme of protecting autonomy was at the forefront of the national
guidelines. The option to pursue genetic testing is important to minors too. As one student
describes, “I disagree with The American Society of Human Genetics’ position statement. It
should be encouraged for adolescents to take predictive or pre-dispositional testing.
However a requirement should be that the teenager must see a genetics counselor who can
explain to them exactly what it means to get tested and all of the possible outcomes” (Essay
216, AD, Not Defer). This emphasizes the idea presented by HGSA that states a genetic test
should be considered as an option on the basis of maturity instead of age after a psychosocial
assessment.
It is clear from our analysis of the student essays that adolescents have well-formed
opinions and insights about predictive genetic testing for adult onset conditions. Current
guidelines acknowledge some flexibility on the issue of testing a minor; however, this
flexibility is limited. Minors have shown that their standpoint on this matter is exceedingly
individual and varies from person to person. Guidelines must acknowledge that minors’
opinions are individualized. As an essential piece of the testing process, guidelines should
recognize that adolescent perspectives are an integral factor when deciding whether or not to
offer genetic testing to for adult onset conditions. It may be beneficial to implement more
progressive guidelines reflecting this notion by considering each minor capable of assent on a
case-by-case basis.
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Appendix I: Complete list of codes and frequency of use in BRCA essays.

Appendix II: Complete list of codes and frequency of use in Alzheimer’s essays.

